Watch our webinar outlining the next general central lab services that provide lab assessments, kits, logistics support, and delivery of data in certain formats. Frontage can provide lab testing on both medical diagnostics and clinical trial spaces.
Register to gain access to gated resources.
Thank you for registering!
You may now view the resource below.
Fascin is an actin-bundling protein that has been linked to tumor cell migration, invasion, metastasis, disease progression and mortality, thus serving as a novel cancer biomarker. In this paper, we develop and validate an LC-MS/MS method for the quantification of fascin proteins in human serum.
Frontage develops a full validation of the XTMAB-16 NAb (neutralizing antibody) assay with acceptable drug and target tolerances to guide future clinical trials.
Frontage’s Biologics, Gene, and Cell Therapy Operations (BGC) Unit supports the development of biologics products. We develop complex analytical techniques to support drug substances, drug products, comparability studies, and stability programs.